Advertisement

Topics

Abstracts Unveiled Ahead of ASCO, One Study Pits Novartis and Gilead CAR-T Therapies Head-to-Head

20:00 EDT 16 May 2018 | BioSpace

Wednesday was the big day for pharma and biotech companies to unveil abstracts ahead of the annual American Society of Oncology meeting in Chicago next month. Some companies have unveiled positive results that are making investors happy, while others… not so much.

Original Article: Abstracts Unveiled Ahead of ASCO, One Study Pits Novartis and Gilead CAR-T Therapies Head-to-Head

NEXT ARTICLE

More From BioPortfolio on "Abstracts Unveiled Ahead of ASCO, One Study Pits Novartis and Gilead CAR-T Therapies Head-to-Head"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...